Biomarkers in NASH Drug Development Webinar

Biomarkers in NASH Drug Development: Using Cytokeratin 18 as a Secondary Endpoint in Clinical Trials

Biomarkers, Clinical Trials, Life Sciences, Pharmaceutical

  • Monday, October 22, 2018 | 11am EDT (NA) / 4pm BST (UK) / 5pm CEST (EU-Central)
  • 60 min
Read Blog

 

Leave a Reply

Your email address will not be published. Required fields are marked *